This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peña, C.
Right arrow Articles by Gudiol, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peña, C.
Right arrow Articles by Gudiol, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 1998, p. 53-58, Vol. 42, No. 1
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum beta -Lactamases

Carmen Peña,1,* Miquel Pujol,1 Carmen Ardanuy,2 Asumpta Ricart,3 Roman Pallares,1 Josefina Liñares,2 Javier Ariza,1 and Francisco Gudiol1

Infectious Disease Service,1 Microbiology Service,2 and Intensive Care Unit Service,3 Hospital de Bellvitge, Universidad de Barcelona, Barcelona, Spain

Received 18 August 1997/Returned for modification 8 September 1997/Accepted 21 October 1997

An outbreak due to extended-spectrum beta -lactamase-producing Klebsiella pneumoniae (ESBL-KP) was detected from May 1993 to June 1995. A total of 145 patients, particularly patients in intensive care units (ICUs) (107 patients [72%]), were colonized or infected. Infection developed in 92 (63%) patients, and primary bacteremia caused by ESBL-KP was the most frequent infection (40 of 92 patients [43%]). A single clone of ESBL-KP was identified by pulsed-field gel electrophoresis analysis throughout the whole period, and no molecular epidemiological relationship could be found between the epidemic strain and non-ESBL-KP isolates. To determine risk factors for ESBL-KP infection weekly rectal swabs were obtained in three serial incidence surveys (470 patients); the probabilities of carriage of ESBL-KP in the digestive tract were 33% (October and November 1993), 40% (May and June 1994), and 0% (October and November 1995) at 10 days of ICU admission. A logistic regression model identified prior carriage of ESBL-KP in the digestive tract (odds ratio, 3.4; 95% confidence interval 1.1 to 10.4) as an independent variable associated with ESBL-KP infection. A statistically significant correlation was observed between the restricted use of oxyimino-beta -lactams (189 defined daily doses [DDD]/1,000 patient-days to 24 DDD/1,000 patient-days) and the trends of ESBL-KP infection (r = 0.7; P = 0.03).

* Corresponding author. Mailing address: Infectious Disease Service, Hospital de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain. Phone: 011-34-3-3359011, ext. 2488. Fax: 011-34-3-2633775. E-mail: mpujol{at}csv.scs.es.

Antimicrobial Agents and Chemotherapy, January 1998, p. 53-58, Vol. 42, No. 1
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Farber, J., Moder, K.-A., Layer, F., Tammer, I., Konig, W., Konig, B. (2008). Extended-Spectrum Beta-Lactamase Detection with Different Panels for Automated Susceptibility Testing and with a Chromogenic Medium. J. Clin. Microbiol. 46: 3721-3727 [Abstract] [Full Text]  
  • Kim, J. Y., Sohn, J. W., Park, D. W., Yoon, Y. K., Kim, Y. M., Kim, M. J. (2008). Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. J Antimicrob Chemother 62: 416-421 [Abstract] [Full Text]  
  • Valverde, A., Grill, F., Coque, T. M., Pintado, V., Baquero, F., Canton, R., Cobo, J. (2008). High Rate of Intestinal Colonization with Extended-Spectrum-{beta}-Lactamase-Producing Organisms in Household Contacts of Infected Community Patients. J. Clin. Microbiol. 46: 2796-2799 [Abstract] [Full Text]  
  • Lavilla, S., Gonzalez-Lopez, J. J., Miro, E., Dominguez, A., Llagostera, M., Bartolome, R. M., Mirelis, B., Navarro, F., Prats, G. (2008). Dissemination of extended-spectrum {beta}-lactamase-producing bacteria: the food-borne outbreak lesson. J Antimicrob Chemother 61: 1244-1251 [Abstract] [Full Text]  
  • Valverde, A., Coque, T. M., Garcia-San Miguel, L., Baquero, F., Canton, R. (2008). Complex molecular epidemiology of extended-spectrum -lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. J Antimicrob Chemother 61: 64-72 [Abstract] [Full Text]  
  • Yang, K., Guglielmo, B J. (2007). Diagnosis and Treatment of Extended-Spectrum and AmpC {beta}-Lactamase-Producing Organisms. The Annals of Pharmacotherapy 41: 1427-1435 [Abstract] [Full Text]  
  • Manzur, A., Tubau, F., Pujol, M., Calatayud, L., Dominguez, M. A., Pena, C., Sora, M., Gudiol, F., Ariza, J. (2007). Nosocomial Outbreak Due to Extended-Spectrum-Beta-Lactamase- Producing Enterobacter cloacae in a Cardiothoracic Intensive Care Unit. J. Clin. Microbiol. 45: 2365-2369 [Abstract] [Full Text]  
  • Castinel, A., Duignan, P. J., Pomroy, W. E., Lopez-Villalobos, N., Gibbs, N. J., Chilvers, B. L., Wilkinson, I. S. (2007). NEONATAL MORTALITY IN NEW ZEALAND SEA LIONS (PHOCARCTOS HOOKERI) AT SANDY BAY, ENDERBY ISLAND, AUCKLAND ISLANDS FROM 1998 TO 2005. J Wildl Dis 43: 461-474 [Abstract] [Full Text]  
  • Paauw, A., Verhoef, J., Fluit, A. C., Blok, H. E. M., Hopmans, T. E. M., Troelstra, A., Leverstein-van Hall, M. A. (2007). Failure To Control an Outbreak of qnrA1-Positive Multidrug-Resistant Enterobacter cloacae Infection despite Adequate Implementation of Recommended Infection Control Measures. J. Clin. Microbiol. 45: 1420-1425 [Abstract] [Full Text]  
  • Glupczynski, Y., Berhin, C., Bauraing, C., Bogaerts, P. (2007). Evaluation of a New Selective Chromogenic Agar Medium for Detection of Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae. J. Clin. Microbiol. 45: 501-505 [Abstract] [Full Text]  
  • Chouchani, C., Berlemont, R., Masmoudi, A., Galleni, M., Frere, J.-M., Belhadj, O., Ben-Mahrez, K. (2006). A Novel Extended-Spectrum TEM-Type {beta}-Lactamase, TEM-138, from Salmonella enterica Serovar Infantis.. Antimicrob. Agents Chemother. 50: 3183-3185 [Abstract] [Full Text]  
  • Mena, A., Plasencia, V., Garcia, L., Hidalgo, O., Ayestaran, J. I., Alberti, S., Borrell, N., Perez, J. L., Oliver, A. (2006). Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development.. J. Clin. Microbiol. 44: 2831-2837 [Abstract] [Full Text]  
  • Anderson, D. J., Engemann, J. J., Harrell, L. J., Carmeli, Y., Reller, L. B., Kaye, K. S. (2006). Predictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae.. Antimicrob. Agents Chemother. 50: 1715-1720 [Abstract] [Full Text]  
  • Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
  • Graffunder, E. M., Preston, K. E., Evans, A. M., Venezia, R. A. (2005). Risk factors associated with extended-spectrum {beta}-lactamase-producing organisms at a tertiary care hospital. J Antimicrob Chemother 56: 139-145 [Abstract] [Full Text]  
  • Hernandez, J. R., Martinez-Martinez, L., Canton, R., Coque, T. M., Pascual, A., Spanish Group for Nosocomial Infections (GEIH), (2005). Nationwide Study of Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum {beta}-Lactamases in Spain. Antimicrob. Agents Chemother. 49: 2122-2125 [Abstract] [Full Text]  
  • Martin, C., Ofotokun, I., Rapp, R., Empey, K., Armitstead, J., Pomeroy, C., Hoven, A., Evans, M. (2005). Results of an antimicrobial control program at a university hospital. Am J Health Syst Pharm 62: 732-738 [Abstract] [Full Text]  
  • Zaoutis, T. E., Goyal, M., Chu, J. H., Coffin, S. E., Bell, L. M., Nachamkin, I., McGowan, K. L., Bilker, W. B., Lautenbach, E. (2005). Risk Factors for and Outcomes of Bloodstream Infection Caused by Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella Species in Children. Pediatrics 115: 942-949 [Abstract] [Full Text]  
  • Jacoby, G. A., Munoz-Price, L. S. (2005). The New {beta}-Lactamases. NEJM 352: 380-391 [Full Text]  
  • Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., Choe, K.-W. (2004). Bloodstream Infections Due to Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy. Antimicrob. Agents Chemother. 48: 4574-4581 [Abstract] [Full Text]  
  • Valverde, A., Coque, T. M., Sanchez-Moreno, M. P., Rollan, A., Baquero, F., Canton, R. (2004). Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in Spain. J. Clin. Microbiol. 42: 4769-4775 [Abstract] [Full Text]  
  • Senn, L., Burnand, B., Francioli, P., Zanetti, G. (2004). Improving appropriateness of antibiotic therapy: randomized trial of an intervention to foster reassessment of prescription after 3 days. J Antimicrob Chemother 53: 1062-1067 [Abstract] [Full Text]  
  • Bantar, C., Vesco, E., Heft, C., Salamone, F., Krayeski, M., Gomez, H., Coassolo, M. A., Fiorillo, A., Franco, D., Arango, C., Duret, F., Oliva, M. E. (2004). Replacement of Broad-Spectrum Cephalosporins by Piperacillin-Tazobactam: Impact on Sustained High Rates of Bacterial Resistance. Antimicrob. Agents Chemother. 48: 392-395 [Abstract] [Full Text]  
  • Miranda, G., Castro, N., Leanos, B., Valenzuela, A., Garza-Ramos, U., Rojas, T., Solorzano, F., Chihu, L., Silva, J. (2004). Clonal and Horizontal Dissemination of Klebsiella pneumoniae Expressing SHV-5 Extended-Spectrum {beta}-Lactamase in a Mexican Pediatric Hospital. J. Clin. Microbiol. 42: 30-35 [Abstract] [Full Text]  
  • Feldman, R. B., Rhew, D. C., Wong, J. Y., Charles, R. A., Goetz, M. B. (2003). Azithromycin Monotherapy for Patients Hospitalized With Community-Acquired Pneumonia: A 31/2-Year Experience From a Veterans Affairs Hospital. Arch Intern Med 163: 1718-1726 [Abstract] [Full Text]  
  • Ben-Hamouda, T., Foulon, T., Ben-Cheikh-Masmoudi, A., Fendri, C., Belhadj, O., Ben-Mahrez, K. (2003). Molecular epidemiology of an outbreak of multiresistant Klebsiella pneumoniae in a Tunisian neonatal ward. J Med Microbiol 52: 427-433 [Abstract] [Full Text]  
  • Gruteke, P., Goessens, W., van Gils, J., Peerbooms, P., Lemmens-den Toom, N., van Santen-Verheuvel, M., van Belkum, A., Verbrugh, H. (2003). Patterns of Resistance Associated with Integrons, the Extended-Spectrum {beta}-Lactamase SHV-5 Gene, and a Multidrug Efflux Pump of Klebsiella pneumoniae Causing a Nosocomial Outbreak. J. Clin. Microbiol. 41: 1161-1166 [Abstract] [Full Text]  
  • Rasheed, J. K., Anderson, G. J., Queenan, A. M., Biddle, J. W., Oliver, A., Jacoby, G. A., Bush, K., Tenover, F. C. (2002). TEM-71, a Novel Plasmid-Encoded, Extended-Spectrum {beta}-Lactamase Produced by a Clinical Isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 46: 2000-2003 [Abstract] [Full Text]  
  • Sahloff, E. G., Martin, S. J. (2002). Extended-Spectrum {beta}-Lactamase Resistance in the ICU. Journal of Pharmacy Practice 15: 96-105 [Abstract]  
  • Bradford, P. A. (2001). Extended-Spectrum {beta}-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat. Clin. Microbiol. Rev. 14: 933-951 [Abstract] [Full Text]  
  • Silva, J., Gatica, R., Aguilar, C., Becerra, Z., Garza-Ramos, U., Velazquez, M., Miranda, G., Leanos, B., Solorzano, F., Echaniz, G. (2001). Outbreak of Infection with Extended-Spectrum {beta}-Lactamase-Producing Klebsiella pneumoniae in a Mexican Hospital. J. Clin. Microbiol. 39: 3193-3196 [Abstract] [Full Text]  
  • Mammeri, H., Laurans, G., Eveillard, M., Castelain, S., Eb, F. (2001). Coexistence of SHV-4- and TEM-24-Producing Enterobacter aerogenes Strains before a Large Outbreak of TEM-24-Producing Strains in a French Hospital. J. Clin. Microbiol. 39: 2184-2190 [Abstract] [Full Text]  
  • Rasheed, J. K., Anderson, G. J., Yigit, H., Queenan, A. M., Doménech-Sánchez, A., Swenson, J. M., Biddle, J. W., Ferraro, M. J., Jacoby, G. A., Tenover, F. C. (2000). Characterization of the Extended-Spectrum beta -Lactamase Reference Strain, Klebsiella pneumoniae K6 (ATCC 700603), Which Produces the Novel Enzyme SHV-18. Antimicrob. Agents Chemother. 44: 2382-2388 [Abstract] [Full Text]  
  • ISAACS, D. (2000). Rationing antibiotic use in neonatal units. Arch. Dis. Child. Fetal Neonatal Ed. 82: 1F-2 [Full Text]  
  • Szabó, D., Filetóth, Z., Szentandrássy, J., Némedi, M., Tóth, E., Jeney, C., Kispál, G., Rozgonyi, F. (1999). Molecular Epidemiology of a Cluster of Cases Due to Klebsiella pneumoniae Producing SHV-5 Extended-Spectrum beta -Lactamase in the Premature Intensive Care Unit of a Hungarian Hospital. J. Clin. Microbiol. 37: 4167-4169 [Abstract] [Full Text]  
  • Royle, J., Halasz, S., Eagles, G., Gilbert, G., Dalton, D., Jelfs, P., Isaacs, D. (1999). Outbreak of extended spectrum beta  lactamase producing Klebsiella pneumoniae in a neonatal unit. Arch. Dis. Child. Fetal Neonatal Ed. 80: 64F-68 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»